Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-139026
Filing Date
2020-05-11
Accepted
2020-05-11 16:06:46
Documents
63
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d899821d10q.htm 10-Q 457426
2 EX-31.1 d899821dex311.htm EX-31.1 10326
3 EX-31.2 d899821dex312.htm EX-31.2 10311
4 EX-32.1 d899821dex321.htm EX-32.1 4376
5 EX-32.2 d899821dex322.htm EX-32.2 4289
  Complete submission text file 0001193125-20-139026.txt   3711597

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20200331.xml EX-101.INS 836253
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20200331.xsd EX-101.SCH 39633
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20200331_cal.xml EX-101.CAL 37641
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20200331_def.xml EX-101.DEF 144074
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20200331_lab.xml EX-101.LAB 315541
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20200331_pre.xml EX-101.PRE 238867
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 20864793
SIC: 2834 Pharmaceutical Preparations